Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Web-based Mobile Health Application for Patients With Liver Cirrhosis (ReLiver-N App) [NA]
This document reports the completion of a clinical trial evaluating a web-based mobile health application (ReLiver-N App) for patients with …
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: To Compare the Safety and Efficacy of Balloon Occluded/Plug Assisted Retrograde Transvenous Obliteration With Endoscopic Variceal Obturation for Primary Prophylaxis of Gastric Varices With Large Spontaneous Shunt [NA]
A completed clinical trial evaluating Balloon Occluded/Plug Assisted Retrograde Transvenous Obliteration versus Endoscopic Variceal Obturati…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) [Phase 2]
A Phase 2 study evaluating BI 685509 alone or with empagliflozin for liver cirrhosis due to viral hepatitis or non-alcoholic steatohepatitis…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
This document outlines a clinical trial evaluating patterns and short-term renal outcomes in patients with liver cirrhosis at Al-Rajhi Liver…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial [Phase 4]
This clinical trial update describes stopping proton-pump inhibitor treatment in patients with liver cirrhosis within a double-blind, placeb…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis [Phase 2]
Phase 2 trial evaluating simvastatin to prevent hepatocellular carcinoma in patients with liver cirrhosis; results have been posted and the …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Early TIPS in Patients With Liver Cirrhosis and Ascites [NA]
A clinical trial update indicating that early TIPS (transjugular intrahepatic portosystemic shunt) is being explored in patients with liver …
-
FDA approval · 2025-04-03FDA Approved: BUMETANIDE — Original Application (First Nation Group, LLC)
FDA approves bumetanide under an Original Application filed by First Nation Group, LLC (ANDA219291).
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: To Evaluate the Feasibility of Collecting Duodenal Fluid With SIMBA Capsules [NA]
Clinical trial update on the feasibility of collecting duodenal fluid using SIMBA capsules in liver cirrhosis patients; the study is not yet…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care [NA]
This clinical trial update reports results of a data-driven implementation strategy designed to improve the quality of care for liver cirrho…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control Trial [NA]
A completed randomized controlled trial evaluating the effects of home-based aerobic and resistance training in individuals with chronic liv…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). [Phase 2]
Phase 2 clinical trial evaluating a combinatorial therapy using albumin and enoxaparin in patients with decompensated cirrhosis at high risk…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection with Hemophilia (OP-724-H201) [Phase 2]
A Phase 2 study of Foscenvivint in liver cirrhosis due to HIV/HCV co-infection with hemophilia is listed as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis
Clinical trial update reporting the completion of a study on predicting multidrug-resistant bacterial infections in patients with liver cirr…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
ClinicalTrials.gov entry for a case-control study comparing the Glycotest HCC Panel to AFP for early detection of hepatocellular carcinoma; …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma
This clinical trial update indicates that Holmium-166 transarterial radioembolization for hepatocellular carcinoma is currently recruiting, …
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Optimized Remission in Alcohol-related Liver Cirrhosis [NA]
This clinical trial update describes 'Optimized Remission in Alcohol-related Liver Cirrhosis,' sponsored by Copenhagen University Hospital, …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
This clinical trial update discusses a noninvasive breath test being studied to detect liver cancer and monitor liver conditions, with recru…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis
A completed clinical trial evaluating the FibroTouch non-invasive device for assessing liver fibrosis and cirrhosis has posted results. The …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Palliative Care for Patients With Liver Cirrhosis
An ongoing clinical trial evaluating palliative care for patients with liver cirrhosis is currently enrolling by invitation. The sponsor is …
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) [NA]
A completed clinical trial evaluated the efficacy of albumin dialysis using the MARS system to treat hepatic encephalopathy in patients with…
-
FDA approval · 2025-02-27FDA Approved: BUMETANIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for bumetanide, a loop diuretic used to treat edema due to congestive heart failur…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis. [NA]
It reports a clinical trial evaluating the safety and effectiveness of sulfasalazine for liver fibrosis and cirrhosis, with recruitment ongo…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Colonic Polypectomy in Cirrhotic Patients With Portal Hypertension
Clinical trial update describing a study of colonic polypectomy in patients with liver cirrhosis and portal hypertension; the trial is activ…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Influence of Sarcopenia on the Course of the Diseases
This clinical trial update notes a study investigating how sarcopenia influences the course of liver cirrhosis and cancer, with related cond…